Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement inhibition in C3 glomerulopathy.

Seminars in immunology - 1 Jun 2016

Nester Carla M, Smith Richard J H

Abstract excerpt

C3 glomerulopathy (C3G) describes a spectrum of glomerular diseases defined by shared renal biopsy pathology: a predominance of C3 deposition on immunofluorescence with electron microscopy permitting disease sub-classification. Complement dysregulation underlies the observed pathology, a causal relationship that is supported by well described studies of genetic and acquired drivers of disease. In this article, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Complement C3
Share to Complement Pathway, Alternative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Glomerulonephritis, Membranous

Share to Immunotherapy

Share to Kidney

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 27402056
DOI: 10.1016/j.smim.2016.06.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement inhibition in C3 glomerulopathy.PMID 27402056Read ↗

C3 Glomerulopathy: A Current Perspective in an Evolving LandscapeSemantic proximity Read ↗

Recent insights into C3 glomerulopathySemantic proximity Read ↗

C3 glomerulopathy: what's in a name?Semantic proximity Read ↗

Acquired and genetic determinants of disease phenotype and therapeutic strategies in C3 glomerulopathy and immunoglobulin-associated MPGNSemantic proximity Read ↗

C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulationSemantic proximity Read ↗

C3 Glomerulopathy: A Review with Emphasis on Ultrastructural FeaturesSemantic proximity Read ↗

C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.Semantic proximity Read ↗

Defining the Complement Biomarker Profile of C3 GlomerulopathySemantic proximity Read ↗

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.Semantic proximity Read ↗

Complement and Complement Targeting Therapies in Glomerular DiseasesSemantic proximity Read ↗

C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.Semantic proximity Read ↗

The role of complement in C3 glomerulopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.